Group One Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,452
| Closed | -$1.19M | – | 7955 |
|
|
2025
Q1 | $1.01M | Sell |
11,452
-35,742
| -76% | -$3.49M | ﹤0.01% | 2455 |
|
|
2024
Q4 | $4.12M | Sell |
47,194
-3,267
| -6% | -$299K | 0.01% | 1308 |
|
|
2024
Q3 | $4.67M | Buy |
+50,461
| New | +$5.01M | 0.01% | 1055 |
|
|
2023
Q4 | – | Sell |
-53,858
| Closed | -$3.49M | – | 7411 |
|
|
2023
Q3 | $2.7M | Buy |
53,858
+27,583
| +105% | +$1.47M | 0.01% | 1391 |
|
|
2023
Q2 | $1.66M | Buy |
26,275
+14,671
| +126% | +$798K | 0.01% | 1890 |
|
|
2023
Q1 | $522K | Buy |
11,604
+5,228
| +82% | +$236K | ﹤0.01% | 2741 |
|
|
2022
Q4 | $279K | Buy |
6,376
+1,704
| +36% | +$81.7K | ﹤0.01% | 3563 |
|
|
2022
Q3 | $308K | Buy |
4,672
+4,416
| +1,725% | +$284K | ﹤0.01% | 3708 |
|
|
2022
Q2 | $13K | Buy |
+256
| New | +$15K | ﹤0.01% | 6592 |
|
|
2022
Q1 | – | Sell |
-1,500
| Closed | -$108K | – | 8041 |
|
|
2021
Q4 | $161K | Sell |
1,500
-4,000
| -73% | -$418K | ﹤0.01% | 5294 |
|
|
2021
Q3 | $565K | Buy |
5,500
+5,067
| +1,170% | +$472K | ﹤0.01% | 4043 |
|
|
2021
Q2 | $38K | Buy |
433
+100
| +30% | +$9.16K | ﹤0.01% | 6787 |
|
|
2021
Q1 | $32K | Buy |
+333
| New | +$33.2K | ﹤0.01% | 6498 |
|
|
2020
Q1 | – | Sell |
-8,167
| Closed | -$526K | – | 5270 |
|
|
2019
Q4 | $654K | Buy |
8,167
+5,324
| +187% | +$399K | ﹤0.01% | 2219 |
|
|
2019
Q3 | $209K | Buy |
+2,843
| New | +$246K | ﹤0.01% | 3042 |
|
|
2019
Q1 | – | Sell |
-7,158
| Closed | -$386K | – | 4818 |
|
|
2018
Q4 | $386K | Buy |
7,158
+3,883
| +119% | +$236K | ﹤0.01% | 2169 |
|
|
2018
Q3 | $256K | Sell |
3,275
-2,534
| -44% | -$176K | ﹤0.01% | 2834 |
|
|
2018
Q2 | $369K | Buy |
+5,809
| New | +$462K | ﹤0.01% | 2555 |
|
|
2017
Q2 | – | Sell |
-2,781
| Closed | -$111K | – | 4749 |
|
|
2017
Q1 | $111K | Buy |
2,781
+2,024
| +267% | +$72.5K | ﹤0.01% | 2904 |
|
|
2016
Q4 | $21K | Buy |
757
+606
| +401% | +$18.3K | ﹤0.01% | 3681 |
|
|
2016
Q3 | $4K | Sell |
151
-749
| -83% | -$18.6K | ﹤0.01% | 4250 |
|
|
2016
Q2 | $18K | Hold |
900
| – | – | ﹤0.01% | 3831 |
|
|
2016
Q1 | $16K | Buy |
+900
| New | +$15.6K | ﹤0.01% | 3843 |
|
Other funds holding BPMC
IA
HNB
Group One Trading's BPMC Position: Q2 2025 in Review
Group One Trading sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 11,452 shares — an estimated $1.19M sold.
Group One Trading first reported a position in BPMC in Q1 2016 and held it in 23 quarters. The position peaked at $4.67M in Q3 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.
- Group One Trading reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 11,452 Blueprint Medicines shares in Q2 2025, an estimated $1.19M.
- Group One Trading first reported a position in Blueprint Medicines in Q1 2016 and held it in 23 quarters.
- Group One Trading's Blueprint Medicines position peaked at $4.67M in Q3 2024.
- 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.